Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1274

2'-Fucosyllactose

Intended Use: As an ingredient in non-exempt infant formula for term infants and formula for young children (>12 months) at a maximum use level of 2.4 g/L as consumed, and in other food categories at the maximum levels shown in Table 1 of FDA's response letter.
Basis: Scientific procedures
Notifier: Tianjin Hesheng Biotechnology Co., Ltd.
Notifier Address: No. 1201, Building 6, Artificial Intelligence Industrial Park
Xiqing Economic and Technological Development Zone, Tianjin
CHINA
GRAS Notice (releasable information): GRN 1274 (in PDF) (6.3 MB)
  Part 2: GRN 1274 amendments (in PDF) (1.1 MB)
Date of closure: Dec 8, 2025
FDA's Letter: FDA has no questions (in PDF) (353 kB)
-
-